| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2008 | WO2008106619A2 Indenoisoquinolinone analogs and methods of use thereof |
| 09/04/2008 | WO2008106600A1 Bazedoxifene bis-phosphorates |
| 09/04/2008 | WO2008106594A2 Inhibitors of nucleophosmin (npm) and methods for inducing apoptosis |
| 09/04/2008 | WO2008106584A1 O-desulfated heparins treating acute exacerbations of chronic obstructive pulmonary disease |
| 09/04/2008 | WO2008106576A1 Phototherapy treatment and device to improve the appearance of nails and skin |
| 09/04/2008 | WO2008106571A2 Sustained release parenteral formulations of buprenorphine |
| 09/04/2008 | WO2008106569A1 Renin inhibitors for the treatment of hypertension in patients with high sodium diet |
| 09/04/2008 | WO2008106536A1 Use of silodosin in a once daily administration for treating benign prostatic hyperplasia |
| 09/04/2008 | WO2008106524A1 Use of histone deacetylase inhibitors for the treatment of central nervous system metastases |
| 09/04/2008 | WO2008106479A2 Poly(1,4-piperazin-2-ones) as rod-like protein- protein interaction inhibitors and their production |
| 09/04/2008 | WO2008106437A1 Compositions and methods for pharmacogenomic screening of cyp2c9 and vkorc1 |
| 09/04/2008 | WO2008106408A1 Treatment of cancer with bio and chemotherapy |
| 09/04/2008 | WO2008106401A1 Very-pure superporous hydrogels having outstanding swelling propertles |
| 09/04/2008 | WO2008106373A1 Product containing inactivated probiotic for children or infants |
| 09/04/2008 | WO2008106372A1 Method for treating or preventing systemic inflammation |
| 09/04/2008 | WO2008106248A1 Method of cancer treatment with naphthol analogs |
| 09/04/2008 | WO2008106228A2 Methods and compositions for normalizing meibomian gland secretions |
| 09/04/2008 | WO2008106227A1 Isomers of inositol niacinate and uses thereof |
| 09/04/2008 | WO2008106226A2 Macrolide compounds and methods of making and using the same |
| 09/04/2008 | WO2008106224A1 Macrolide compounds and methods of making and using the same |
| 09/04/2008 | WO2008106213A1 Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome. |
| 09/04/2008 | WO2008106202A1 Theramutein modulators |
| 09/04/2008 | WO2008106186A2 Activated polyoxazolines and compositions comprising the same |
| 09/04/2008 | WO2008106177A2 Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy |
| 09/04/2008 | WO2008106168A1 Combination of imidazo [1,5-a] pyrazinyl derivatives with an agent that inhibits serine phosphorylation of irs1 for use in the treatment of cancer |
| 09/04/2008 | WO2008106166A2 Methods for the treatment of liver diseases using specified matrix metalloproteinase (mmp) inhibitors |
| 09/04/2008 | WO2008106159A1 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound |
| 09/04/2008 | WO2008106144A2 Implants for the treatment of psychiatric states |
| 09/04/2008 | WO2008106139A1 Inhibitors of serine proteases for the treatment of hcv infections |
| 09/04/2008 | WO2008106131A2 Combination therapy for treatment of immune disorders |
| 09/04/2008 | WO2008106129A2 Polymeric micelles for combination drug delivery |
| 09/04/2008 | WO2008106128A2 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 09/04/2008 | WO2008106102A2 Inhibitors of rtp801 and their use in disease treatment |
| 09/04/2008 | WO2008106092A1 Enantiomers of amino-phenyl-acetic acid octadec- 9- (z) enyl ester, their salts and their uses |
| 09/04/2008 | WO2008106091A1 Use of long-chain alcohol derivatives for the treatment of alopecia areata |
| 09/04/2008 | WO2008106081A1 Topical formulations containing leukotriene receptor antagonist and use for treatment or prevention of capsular contracture, scarring or hyperpigmentation |
| 09/04/2008 | WO2008106077A1 Substituted benzodiazepinones, benzoxazepinones and benzothiazepinones as sodium channel blockers |
| 09/04/2008 | WO2008106047A2 Carbamate compounds |
| 09/04/2008 | WO2008105983A1 Mineral absorption from the stomach |
| 09/04/2008 | WO2008105968A1 Novel seh inhibitors and their use |
| 09/04/2008 | WO2008105920A1 Antihistamine combination |
| 09/04/2008 | WO2008105872A1 Drug combinations to treat drug resistant tumors |
| 09/04/2008 | WO2008105835A2 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 09/04/2008 | WO2008105824A2 Direct detection of ligand-antiligand interactions by nanoscale switching |
| 09/04/2008 | WO2008105808A2 FORMULATIONS OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES |
| 09/04/2008 | WO2008105803A1 Topical formulations containing leukotriene receptor antagonist and uses thereof |
| 09/04/2008 | WO2008105801A2 Projectile resistant material |
| 09/04/2008 | WO2008105794A1 Process for the purification of carvedilol or its salts thereof |
| 09/04/2008 | WO2008105607A1 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists |
| 09/04/2008 | WO2008105583A1 Crude exopolysaccharides produced from tremella fuciformis mycellium having hypoglycemic activity and preparation method thereof |
| 09/04/2008 | WO2008105533A1 Adiponectin secretion-stimulating agent comprising capsinoid compound |
| 09/04/2008 | WO2008105526A1 Macrocyclic compound |
| 09/04/2008 | WO2008105515A1 Novel hydroxamic acid derivative |
| 09/04/2008 | WO2008105504A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| 09/04/2008 | WO2008105498A1 Pharmaceutical composition for ameliorating inflammation induced by il-17 |
| 09/04/2008 | WO2008105497A1 Benzimidazole compound and pharmaceutical use thereof |
| 09/04/2008 | WO2008105495A1 Bis(tetrahydrofuran) compound, method for production of the compound, and use of the compound |
| 09/04/2008 | WO2008105445A1 Transdermal pharmaceutical composition |
| 09/04/2008 | WO2008105442A1 Sulfonamide derivative |
| 09/04/2008 | WO2008105441A1 Poly(amino acid) compound having inhibitory activity on absorption of phosphorus and phosphorus absorption inhibitor |
| 09/04/2008 | WO2008105408A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents |
| 09/04/2008 | WO2008105392A1 3-amino-2-indolylbutyrolactam derivative, process for production of the same, and pharmaceutical agent comprising the same as active ingredient |
| 09/04/2008 | WO2008105386A1 Rexinoid compound having alkoxy group |
| 09/04/2008 | WO2008105384A1 Citrulline-containing tablet |
| 09/04/2008 | WO2008105383A1 Pyrazole derivative and use thereof for medical purposes |
| 09/04/2008 | WO2008105368A1 Amino acid composition |
| 09/04/2008 | WO2008105326A1 Process for production of 2-imino-4-thiazolidinone derivative and 2,4-thiazolidinedione derivative |
| 09/04/2008 | WO2008105325A1 Citrulline-containing beverage |
| 09/04/2008 | WO2008105260A1 Therapeutic agent for ameliorating prognosis after lower limb amputation surgery |
| 09/04/2008 | WO2008105181A1 Pharmaceutical agent for prevention and/or treatment of lower urinary tract symptom |
| 09/04/2008 | WO2008105113A1 Oral disinfectant, food additive comprising the disinfectant |
| 09/04/2008 | WO2008105058A1 Sulfonamides |
| 09/04/2008 | WO2008105038A1 Adhesive patch for mycosis |
| 09/04/2008 | WO2008104993A1 Use of doxycycline in the treatment of idiopathic pulmonary fibrosis |
| 09/04/2008 | WO2008104976A1 Amphipathic carboxylates for the treatment of immune-related disorders |
| 09/04/2008 | WO2008104975A2 Combination therapy, composition and methods for the treatment of cardiovascular disorders |
| 09/04/2008 | WO2008104956A2 Process for the preparation of amorphous cabergoline |
| 09/04/2008 | WO2008104955A1 Azoniatricyclo [3.3.1.0] nonane derivatives as muscarinic receptor antagonists |
| 09/04/2008 | WO2008104925A1 Chromone derivatives for use as antioxidants/preservatives |
| 09/04/2008 | WO2008104920A1 The use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection |
| 09/04/2008 | WO2008104885A1 Methods and compositions for treating at least one upper gastrointestinal symptom |
| 09/04/2008 | WO2008104880A2 Stable solid dosage forms of an antidepressant |
| 09/04/2008 | WO2008104875A1 Oxazolidinones as cholesterol absorption inhibitors |
| 09/04/2008 | WO2008104812A2 C21-de0xy ansamycin derivatives as antitumor agents |
| 09/04/2008 | WO2008104790A1 Salts of a selective beta-2 andrenoceptor agonist |
| 09/04/2008 | WO2008104789A1 Therapeutic compositions |
| 09/04/2008 | WO2008104776A1 Combinations of beta-2-adrenoceptor agonistic benzothiazolone |
| 09/04/2008 | WO2008104756A1 Urea derivatives and their therapeutic use |
| 09/04/2008 | WO2008104755A1 Succinate derivatives and their therapeutic use |
| 09/04/2008 | WO2008104754A1 Novel pyrimidine derivatives 698 |
| 09/04/2008 | WO2008104752A1 Dihydropyridones as elastase inhibitors |
| 09/04/2008 | WO2008104738A1 Improvements in and relating to medicinal compositions |
| 09/04/2008 | WO2008104734A1 Treatment of anxiety disorders with minocycline |
| 09/04/2008 | WO2008104597A2 Sulfonyltryptophanols |
| 09/04/2008 | WO2008104595A1 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
| 09/04/2008 | WO2008104590A2 Novel dosage form |
| 09/04/2008 | WO2008104589A1 Novel dosage form |
| 09/04/2008 | WO2008104584A1 Hydrochloride salt of an azabicyclo[3.2.1]octane derivative |
| 09/04/2008 | WO2008104580A1 New use of glutaminyl cyclase inhibitors |
| 09/04/2008 | WO2008104557A1 Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants |